HemaSphere (Apr 2023)

5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT

  • C.L. Levin,
  • A.K. Koren,
  • S.S.P. Peretz,
  • L.L. Livshits,
  • A.M. Makhro,
  • A.B. Bogdanova,
  • M.G. Gassmann

DOI
https://doi.org/10.1097/01.HS9.0000928448.56489.99
Journal volume & issue
Vol. 7, no. S1
pp. 41 – 42

Abstract

Read online

No abstracts available.